 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Cipla |
| Street 1: | Mumbai Central |
| Street 2: | |
| City: | MUMBAI |
| Province: | |
| Post Code: | 400.008 |
| Country: | India |
| Phone: | +91 22 23082891 |
| Organization Email: | sharadd.jain@cipla.com |
| Web Site: | http://www.cipla.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Manufacturer of high quality medicines Manufacturer of anti-TB drugs Supplying TB drugs to low-income countries through our Global Access programme and supporting the development of new therapies for MDR-TB |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Provision of drugs, diagnostics and commodities |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 26 - 50 |
| Number of part-time staff who are directly involved with TB: | 100 + |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| SUpport through interaction with the national authorities in charge of the RNTCP and provision of medicines through government tenders | |
Geographical Reach | |
| Which country is your headquarters located in: | India |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Angola Bangladesh Bhutan Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Congo Cote d'Ivoire Democratic Republic of the Congo Djibouti Equatorial Guinea Eswatini Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Haiti India Indonesia Iran (Islamic Republic of) Kazakhstan Kenya Kyrgyzstan Lao People's Democratic Republic Lesotho Liberia Madagascar Malawi Malaysia Mali Mauritania Mauritius Mexico Mongolia Morocco Mozambique Namibia Nepal Niger Nigeria Pakistan Papua New Guinea Peru Philippines Republic of Moldova Russian Federation Rwanda Senegal Seychelles Sierra Leone South Africa South Sudan Sri Lanka Sudan Switzerland Tajikistan Thailand Tunisia Turkey Turkmenistan Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uzbekistan Venezuela Viet Nam Yemen Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Supply of 7 anti-TB products used in MDR-TB TB-HIV: Second largest supplier of ARV in the world New TB Drugs: Involved in R&D for new TB products |
|
Declaration | |
| Declaration of interests: CIPLA is a pharmaceutical company sellin medicines, including TB medicines. In addition, CIPLA participates in GDF tenders. | |
| Application date: | March 14, 2015 |
| Last updated: | April 20, 2018 |